Scienture Holdings SCNX
NASDAQ SCNX
$0.14 -0.04 (-20.16%)
As of: Oct 2, 2026 · 11:59 AM EDT

Scienture Holdings (SCNX) Non Operating Interest Expenses (2013 - 2026)

Updated

Scienture Holdings (SCNX) recorded Non Operating Interest Expenses of $269,785 in Q2 2026, down 58.7% from $653,493 a year earlier but up 628.8% from the prior quarter.

Analysis

Scienture Holdings (SCNX) Non Operating Interest Expenses (2013 - 2026) Analysis & Trends

On a TTM basis, Scienture Holdings' Non Operating Interest Expenses came in at $4.27 million as of Jun 30, 2026, up 60.4% year-over-year; for FY2025, it came in at $4.08 million, up 205.7% from FY2024.

  • Annual Non Operating Interest Expenses has increased for three straight years, with a five-year compound annual growth rate of 168.3% (FY2020 to FY2025).
  • Across earlier years, Non Operating Interest Expenses came in at $1.34 million in FY2024 (+16.8%), $1.14 million in FY2023 (+240.0%), $336,206 in FY2022 and $23,590 in FY2021 (-19.7%).
  • Quarterly Non Operating Interest Expenses has ranged from $1,364 in Q1 2022 to $3.94 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Non Operating Interest Expenses rose in three of the last seven quarters, with growth averaging 84.2%.
  • Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 580.9% in Q1 2025, against a decline of 97.3% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $37,019 (Q1 2026), $3.94 million (Q4 2025) and $17,478 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Scienture Holdings 10.68 Mn 10.68 Mn 335,779.00 269,785.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 269,785.00
Mar 31, 2026 37,019.00
Dec 31, 2025 3.94 Mn
Sep 30, 2025 17,478.00
Jun 30, 2025 653,493.00
Mar 31, 2025 670,784.00
Dec 31, 2024 1.29 Mn
Sep 30, 2024 43,200.00
Jun 30, 2024 4,949.00
Mar 31, 2024 98,515.00
Dec 31, 2023 648,319.00
Sep 30, 2023 251,778.00
Jun 30, 2023 180,734.00
Mar 31, 2023 62,392.00
Dec 31, 2022 195,580.00
Sep 30, 2022 130,107.00
Jun 30, 2022 9,155.00
Mar 31, 2022 1,364.00
Dec 31, 2021 2,016.00
Sep 30, 2021 5,622.00
API Access

Scienture Holdings Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SCNX&period=max&api_key=YOUR_API_KEY